NGUYEN, THI PHUONG NHUNG
 Distribuzione geografica
Continente #
EU - Europa 549
AS - Asia 93
SA - Sud America 15
NA - Nord America 7
Totale 664
Nazione #
IT - Italia 545
SG - Singapore 31
CN - Cina 25
VN - Vietnam 25
BR - Brasile 9
ID - Indonesia 4
MX - Messico 4
US - Stati Uniti d'America 3
AR - Argentina 2
CL - Cile 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BY - Bielorussia 1
CO - Colombia 1
GB - Regno Unito 1
HK - Hong Kong 1
IN - India 1
JO - Giordania 1
PK - Pakistan 1
PY - Paraguay 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 664
Città #
Genoa 380
Vado Ligure 124
Rapallo 22
Genova 15
Ho Chi Minh City 8
Beijing 7
Hanoi 6
Bordighera 3
Singapore 3
Curitiba 2
Hải Dương 2
Quảng Ngãi 2
Rio de Janeiro 2
Ajman 1
Amman 1
Ashburn 1
Bandung 1
Bangkok 1
Barra do Corda 1
Basingstoke 1
Biên Hòa 1
Campos dos Goytacazes 1
Chandigarh 1
Changchun 1
Chillán 1
Da Nang 1
Estación Colina 1
Fuzhou 1
Guangzhou 1
Hong Kong 1
Hortolândia 1
Iztacalco 1
Kisaran 1
Makhachkala 1
Medan 1
Mexico City 1
Minsk 1
Peshawar 1
Philadelphia 1
Pontal do Paraná 1
Quận Chín 1
Roldán 1
Rome 1
San Juan 1
San Nicolás de los Garza 1
Soacha 1
South Tangerang 1
Thuận An 1
Tokyo 1
Tuxtla Gutiérrez 1
Uberlândia 1
Totale 614
Nome #
EFFECTS OF PHARMACOLOGICAL GPR17 MODULATION IN THE SOD1G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS 128
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases 77
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 75
Effects of the GPR17 antagonist montelukast on oligodendrocyte dysfunction and disease outcome in the SOD1G93A mouse model of ALS 64
Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders 61
A repurposing approach to improve disease outcome in SOD1G93A mice by counteracting oligodendrocyte dysfunction and neuroinflammation 58
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 51
In-vivo treatment with the GPR17 antagonist montelukast ameliorated the lifespan and delayed the disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 37
Montelukast improves disease progression in the female SOD1G93A mouse model of ALS by restoring oligodendrocyte maturation and counteracting altered glial reactivity 37
Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 34
In-vivo treatment with the GPR17 antagonist montelukast improves lifespan and delays disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 32
Pharmacological blockade of the P2Y-like GPR17 receptor with montelukast delays disease progression by counteracting oligodendrocyte dysfunction in the SOD1G93A mouse model of amyotrophic lateral sclerosis 32
null 1
A repurposing approach to delay disease progression in SOD1G93A mice by counteracting oligodendrocyte dysfunction 1
Totale 688
Categoria #
all - tutte 2.778
article - articoli 923
book - libri 0
conference - conferenze 1.533
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 1 0 0 0 0 2 8 3 6 3
2022/202351 3 0 0 0 0 1 4 2 6 11 18 6
2023/202476 6 4 0 8 4 22 9 6 1 2 8 6
2024/2025284 15 18 9 36 31 31 14 54 2 5 41 28
2025/2026254 65 9 32 45 92 11 0 0 0 0 0 0
Totale 688